DeepMatter subsidiary signs data licensing agreement with the Life Science business of Merck
DeepMatter announce that it has signed a three-year contract with Thieme Chemistry for the supply of technical data services and access to the Group’s proprietary algorithms.
DeepMatter is pleased to announce two appointments to the Board, effective on 1 November 2020. Karen Bach will join as Non-Executive Chair and Fraser Benson will join as Chief Financial Officer.
DeepMatter doubles customer numbers for its machine-learning retrosynthesis tool ICSYNTH
DeepMatter announces collaboration with AstraZeneca focused on improving productivity of compound synthesis using digital technologies enabled with machine learning and artificial intelligence
Having parcipated in the Pioneer Programme, and being sufficiently impressed by the DigitalGlassware™ technology, o2h has elected to pay for the provision of a greater number of user licences. This roll out will enable o2h to use DigitalGlassware™ as part its drug-discovery collaboration with a strategic customer.
DeepMatter and the Institute of Process Research and Development (iPRD) at the University of Leeds, have commenced a project to integrate DeepMatter's technology platform, DigitalGlassware™ within the iPRD's laboratories
DeepMatter is delighted to be collaborating with the University of Nottingham's School of Chemistry, to explore the benefits of the DigitalGlassware™ platform in data capture and analysis within undergraduate chemistry teaching
DeepMatter announces plans to interface its DigitalGlassware™ platform with the Waters Corporation UNIFI™ Scientific Information System, enhancing the quality and accessibility of data for chemists worldwide.
DeepMatter announces collaboration with the Cancer Research UK Beatson Institute within its Drug Discovery Unit to enhance the reproducibility of its chemistry and accelerate drug discovery